🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of depemokimab (GSK3511294...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-20
Trial ID
NCT07701967
Treatments Being Tested
This study is aimed at assessing depemokimab as an add-on medicine for the ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-06-25
Trial ID
NCT07671001
Treatments Being Tested
Depemokimab is being developed as a treatment for individuals with moderate...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-10-20
Trial ID
NCT07177339
Treatments Being Tested
This study will evaluate the efficacy and safety of depemokimab (GSK3511294...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-04-18
Trial ID
NCT05281523
Treatments Being Tested
This is a multi-center, randomized, placebo-controlled, double-blind, paral...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-03-17
Trial ID
NCT04719832
Treatments Being Tested
Depemokimab is being developed as a treatment for individuals with moderate...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-06-23
Trial ID
NCT06961214
Treatments Being Tested
This study will compare the pharmacokinetics, safety, tolerability, and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-12-13
Trial ID
NCT05602025
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389
This study aims to investigate the efficacy and safety of depemokimab compa...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2022-07-14
Trial ID
NCT05263934
Treatments Being Tested
The aim of this study is to evaluate the efficacy of depemokimab administer...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-03-13
Trial ID
NCT07456033
Treatments Being Tested